SerenQ Tirzepatide
Price range: £115.00 through £175.00 & Free Shipping
20mg / 40mg
300 units
66.7mcg / 133mcg
Pre-filled pen
FREE SHIPPING
On orders over £200
✓
UK Fast Dispatch
Research Grade
Description
Tirzepatide Pre-Filled Peptide Pen
SerenQ Tirzepatide is a synthetic, long-acting dual agonist peptide supplied
in a sealed, pre-filled pen format. Available in 20mg and 40mg
strengths, both variants use the same 3ml, 300-unit pen platform,
with the concentration varying between strengths.
The pre-filled format provides a consistent, ready-filled research format
without the need to work from a conventional lyophilised vial. Each pen is
supplied in a sealed retail carton with product identification, batch
information, serialisation and QR verification.
Two strengths · One pen format
20mg Tirzepatide
20mg total peptide content in a 3ml pre-filled pen with a graduated
300-unit scale.
40mg Tirzepatide
40mg total peptide content in a 3ml pre-filled pen using the same
graduated 300-unit platform.
Dual Agonist
Tirzepatide is designed to interact with both GLP-1 and GIP receptor
pathways, making it a dual agonist peptide.
Serialised Identification
Each pen carries product identification together with serial and QR
information for authenticity and batch verification.
Tirzepatide 20mg
Tirzepatide 40mg
Concentration & Pen Format
Both variants contain tirzepatide in a 3ml pre-filled pen with a 300-unit
graduated scale. The two strengths differ in total peptide concentration.
The stated concentration is based on the supplied total peptide content
divided by the stated 3ml fill volume. The pen incorporates a graduated
scale for laboratory research handling and volume reference.
What is Tirzepatide?
Tirzepatide is a synthetic, long-acting peptide designed to interact with two
incretin receptor pathways: the GLP-1 receptor and the
GIP receptor. This dual mechanism distinguishes it from
single-receptor GLP-1 agonists.
The compound has been extensively investigated in research relating to
metabolic signalling, glucose regulation, appetite pathways, body weight,
adiposity and related physiological processes.
Structurally, tirzepatide is a 39-amino-acid peptide incorporating a fatty
acid side chain that facilitates reversible albumin binding and contributes
to its long-acting characteristics.
Dual receptor activity
Tirzepatide combines GLP-1 and GIP receptor activity within a single
peptide molecule, making it a prominent subject of incretin research.
Two receptor pathways
GLP-1
A receptor pathway involved in glucose-dependent insulin signalling,
appetite regulation and gastrointestinal processes.
GIP
An additional incretin pathway investigated for its role in pancreatic,
adipose and broader metabolic signalling.
Investigational Research Material
Tirzepatide is an extensively studied peptide with established pharmaceutical
research and development history. However, the SerenQ product described on
this page is supplied as a research-grade reference material
and is not represented as a licensed medicinal product.
Research use only
This product is supplied strictly for laboratory research and analytical
purposes. It is not intended for human or veterinary consumption.
Serialised & QR Verified
Every SerenQ product carries unique identification information. Each pen
and its packaging include serial and batch details together with a QR code
for authenticity verification.
The supplied product can be checked through the SerenQ authentication portal:
Independent Analysis
Results pending
The supplied product information states that this batch is currently
undergoing independent laboratory analysis for purity, identity and potency.
Pre-Filled Pen Format
Both strengths use the same SerenQ pen platform. Tirzepatide is supplied
in a pre-filled format with an integrated graduated scale and visible
dose window for consistent laboratory handling.
Graduated Scale
The pen incorporates a visible graduated scale for volume reference
during research handling.
Sealed Pen Tips
Four individually sealed 32G 0.23 × 4mm pen tips are supplied with
each pen.
Product Traceability
Batch, expiry and serial information provide identification and
traceability for the supplied product.
Protective Packaging
Each pen is supplied inside a rigid retail carton designed for
storage and transport.
Storage Information
Store refrigerated at 2–8°C. Do not freeze.
Keep inside the outer carton and away from direct light.
The supplied specification describes the solution as clear and colourless.
12/2027 for the supplied sealed stock.
Keep out of reach of children and animals.
What’s Included
Tirzepatide Pen
1 × SerenQ Tirzepatide pre-filled peptide pen in the selected
20mg or 40mg strength.
Pen Tips
4 × individually sealed 32G 0.23 × 4mm pen tips.
Retail Carton
Serialised and QR-coded product packaging.
For Research Purposes Only
This product is supplied strictly as a laboratory research chemical.
It is not a medicine, supplement or cosmetic and is not intended for
human or veterinary consumption. Nothing on this page should be interpreted
as medical advice or as a recommendation for use in humans or animals.
The SerenQ Tirzepatide product is supplied as research material and is
separate from any licensed pharmaceutical products containing tirzepatide.
By purchasing this product, the purchaser confirms that they are acquiring
it for legitimate laboratory research or analytical purposes and accept
responsibility for lawful handling and use under the regulations applicable
to them.
Additional information
| choose dosage | 20mg, 40mg |
|---|
Related products
-
Sale!
SerenQ Mots-C 40mg Peptide Pen
Original price was: £95.00.£75.00Current price is: £75.00. -
Sale!
-
Sale!
-
Sale!
Reviews
There are no reviews yet.